Trends in Epilepsy Research
Epidiolex shows promise in some Dravet syndrome patients
03/20/2018
A recent study published in the New England Journal of Medicine (NEJM) shows a purified cannabidiol (CBD) medication called Epidiolex may help to curb seizures in children and young adults with Dravet syndrome. Read More
FAST launches a new biotech to find cures for Angelman syndrome
03/20/2018
The Foundation for Angelamn Syndrome Therapeutics (FAST) launches a new biotech, GeneTx Biotherapeutics LLC (GeneTx), a subsidiary of FAST, for the development and commercialization of an investigational antisense drug, GTX-101, for the treatment of Angelman syndrome (AS), a rare genetic disorder characterized by epilepsy, impaired motor function and speech delays. Read More
Former British Prime Minister shares the lessons he learnt from his son's rare epileptic syndrome
03/02/2018
David Cameron’s son Ivan was born with a neurological disorder that baffled doctors. He was later diagnosed with a rare epileptic syndrome, Ohtahara syndrome. Now, he writes, genomic testing can end the anguish of uncertainty.